We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

628 hedge funds and large institutions have $33.3B invested in Allergan plc in 2014 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 221 increasing their positions, 236 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more first-time investments, than exits

New positions opened: 118 | Existing positions closed: 36

86% more call options, than puts

Call options by funds: $918M | Put options by funds: $493M

38% more funds holding in top 10

Funds holding in top 10: 5373 (+20)

34% more capital invested

Capital invested by funds: $24.9B → $33.3B (+$8.39B)

14% more funds holding

Funds holding: 552628 (+76)

6% less repeat investments, than reductions

Existing positions increased: 221 | Existing positions reduced: 236

Holders
628
Holders Change
+76
Holders Change %
+13.77%
% of All Funds
18.13%
Holding in Top 10
73
Holding in Top 10 Change
+20
Holding in Top 10 Change %
+37.74%
% of All Funds
2.11%
New
118
Increased
221
Reduced
236
Closed
36
Calls
$918M
Puts
$493M
Net Calls
+$426M
Net Calls Change
+$115M

AGN Hedge Fund Activity: Q1 2014 in Review

628 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2014, worth a combined $33.3B — up 34% from $24.9B a quarter earlier.

Buyers outnumbered sellers: 118 funds opened new AGN positions and 36 closed out — a net gain of 82 holders — while 221 added to existing stakes and 236 trimmed.

The largest buyer was Third Point, opening a new position worth an estimated $495M. The largest seller was Viking Global Investors, cutting an estimated $365M.

  • 628 institutional investors held Allergan plc (AGN) as of Q1 2014, up from 552 in Q4 2013.
  • Funds reported $33.3B of Allergan plc stock for Q1 2014, up 34% quarter-over-quarter.
  • 118 funds opened new Allergan plc positions in Q1 2014 and 36 closed out, a net change of +82 holders.
  • The largest Allergan plc buyer in Q1 2014 was Third Point, an estimated $495M added.
  • The largest Allergan plc seller in Q1 2014 was Viking Global Investors, an estimated $365M sold.

Based on aggregated 13F filings for Q1 2014.